Crossmark

Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s13046-023-02809-8

Published Online: 2023-10-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thorel, Lucie

Morice, Pierre-Marie

Paysant, Hippolyte

Florent, Romane

Babin, Guillaume

Thomine, Cécilia

Perréard, Marion

Abeilard, Edwige

Giffard, Florence

Brotin, Emilie

Denoyelle, Christophe

Villenet, Céline

Sebda, Shéhérazade

Briand, Mélanie

Joly, Florence

Dolivet, Enora

Goux, Didier

Blanc-Fournier, Cécile

Jeanne, Corinne

Villedieu, Marie

Meryet-Figuiere, Matthieu

Figeac, Martin

Poulain, Laurent

Weiswald, Louis-Bastien
License Information

Text and Data Mining valid from 2023-10-07

Version of Record valid from 2023-10-07
More Information

Article History

Received: 3 March 2023

Accepted: 22 August 2023

First Online: 7 October 2023

Declarations

:

: The biological collection was declared to the French Ministry of Education, Health and Research (No. DC 2010–1243). Informed consent form was signed by the patient and was obtained under the agreement of the ethical committee “North-West III” (CPP).

: Not applicable.

: The authors have declared that no competing interest exists.

Document is current

Any future updates will be listed below